Cell Biochemistry and Biophysics

, Volume 63, Issue 3, pp 247–259 | Cite as

Effect of Sulforaphane on Growth Inhibition in Human Brain Malignant Glioma GBM 8401 Cells by Means of Mitochondrial- and MEK/ERK-Mediated Apoptosis Pathway

  • Tzuu-Yuan HuangEmail author
  • Weng-Cheng Chang
  • Miin-Yau Wang
  • Yun-Ru Yang
  • Yi-Chiang HsuEmail author
Original Paper


In recent studies, sulforaphane (SFN) has been seen to demonstrate antioxidant and anti-tumor activities as well as potent chemopreventive action against cancer. The present study investigates the anti-proliferation (using MTT assay, SFN demonstrated cytotoxic activity against GBM 8401 cell with IC50 values at 35.52 μM) and induced apoptosis of SFN 24-h treatment in the cells of human brain malignant glioma GBM 8401 cells. We studied the MMP, caspase, MEK/ERK activation, and NF-κB transcription factor activity. Our results indicate that SFN inhibits cell proliferation as well as the activation of apoptosis in GBM 8401 cells. Both effects increased in proportion to the dosage of SFN, and apoptosis was induced via mitochondria- and caspase-dependent pathways. Daily s.c. injections of SFN for 3 weeks in severe combined immunodeficient mice (SCID) with GBM8401 s.c. tumors resulted in a decrease in mean tumor weight of 69–75 % compared with vehicle-treated controls. Our findings suggest that, in addition to the known effects on cancer prevention, SFN may provide antitumor activity in established malignant glioma.


Sulforaphane Malignant glioma Mitochondrial MEK/ERK pathway Apoptosis 



The authors gratefully acknowledge the financial support from Tainan Sin-Lau Hospital (99-01 and 100-01).


  1. 1.
    Mukherjee, S., Bhattacharya, R. K., & Roy, M. (2009). Targeting protein kinase C (PKC) and telomerase by phenethyl isothiocyanate (PEITC) sensitizes PC-3 cells towards chemotherapeutic drug-induced apoptosis. Journal of Environmental Pathology, Toxicology and Oncology, 28(4), 269–282.PubMedGoogle Scholar
  2. 2.
    Smerák, P., Polívková, Z., Stetina, R., et al. (2009). Antimutagenic effect of phenethyl isothiocyanate. Central European Journal of Public Health, 17(2), 86–92.PubMedGoogle Scholar
  3. 3.
    Stan, S. D., Singh, S. V., & Brand, R. E. (2010). Chemoprevention strategies for pancreatic cancer. Nature Reviews Gastroenterology & Hepatology, 7(6), 347–356.Google Scholar
  4. 4.
    Matsuda, T., Maruyama, T., Iizuka, H., et al. (2010). Phthalate esters reveal skin-sensitizing activity of phenethyl isothiocyanate in mice. Food and Chemical Toxicology, 48(6), 1704–1708.PubMedCrossRefGoogle Scholar
  5. 5.
    Herr, I., & Büchler, M. W. (2010). Dietary constituents of broccoli and other cruciferous vegetables: Implications for prevention and therapy of cancer. Cancer Treatment Reviews, 36(5), 377–383.PubMedCrossRefGoogle Scholar
  6. 6.
    Maeda, T., Miyazono, Y., Ito, K., et al. (2010). Oxidative stress and enhanced paracellular permeability in the small intestine of methotrexate-treated rats. Cancer Chemotherapy and Pharmacology, 65(6), 1117–1123.PubMedCrossRefGoogle Scholar
  7. 7.
    Miyoshi, N., Watanabe, E., Osawa, T., et al. (2008). ATP depletion alters the mode of cell death induced by benzyl isothiocyanate. Biochimica et Biophysica Acta, 1782(10), 566–573.PubMedGoogle Scholar
  8. 8.
    Hasegawa, K., Miwa, S., Tsutsumiuchi, K., et al. (2010). Allyl isothiocyanate that induces GST and UGT expression confers oxidative stress resistance on C. elegans, as demonstrated by nematode biosensor. PLoS ONE, 5(2), e9267.PubMedCrossRefGoogle Scholar
  9. 9.
    Mishra, P. K., Panwar, H., Bhargava, A., et al. (2008). Isocyanates induces DNA damage, apoptosis, oxidative stress, and inflammation in cultured human lymphocytes. Journal of Biochemical and Molecular Toxicology, 22(6), 429–440.PubMedCrossRefGoogle Scholar
  10. 10.
    Adsule, S., Banerjee, S., Ahmed, F., et al. (2010). Hybrid anticancer agents: Isothiocyanate-progesterone conjugates as chemotherapeutic agents and insights into their cytotoxicities. Bioorganic & Medicinal Chemistry Letters, 20(3), 1247–1251.CrossRefGoogle Scholar
  11. 11.
    Higdon, J. V., Delage, B., Williams, D. E., et al. (2007). Cruciferous vegetables and human cancer risk: Epidemiologic evidence and mechanistic basis. Pharmacological Research, 55(3), 224–236.PubMedCrossRefGoogle Scholar
  12. 12.
    Li, M., Wang, Q., Lin, W., & Wang, B. (2009). Regulation of ovarian cancer cell adhesion and invasion by chloride channels. International Journal of Gynecological Cancer, 19(4), 526–530.PubMedCrossRefGoogle Scholar
  13. 13.
    D’Agostini, F., Mastracci, L., Izzotti, A., et al. (2009). Modulation by phenethyl isothiocyanate and budesonide of molecular and histopathologic alterations induced by environmental cigarette smoke in mice. Cancer Prevention Research (Philadelphia), 2(6), 546–556.CrossRefGoogle Scholar
  14. 14.
    Kim, M. G., & Lee, H. S. (2009). Growth-inhibiting activities of phenethyl isothiocyanate and its derivatives against intestinal bacteria. Journal of Food Science, 74(8), M467–M471.PubMedCrossRefGoogle Scholar
  15. 15.
    Hayashi, S., Nakamura, E., Kubo, Y., et al. (2008). Impairment by allyl isothiocyanate of gastric epithelial wound repair through inhibition of ion transporters. Journal of Physiology and Pharmacology, 59(4), 691–706.PubMedGoogle Scholar
  16. 16.
    Traka, M. H., Spinks, C. A., Doleman, J. F., et al. (2010). The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a PTEN null preclinical murine model of prostate cancer. Molecular Cancer, 13, 189.CrossRefGoogle Scholar
  17. 17.
    Jiang, H., Shang, X., Wu, H., et al. (2010). Combination treatment with resveratrol and sulforaphane induces apoptosis in human U251 glioma cells. Neurochemical Research, 35(1), 152–161.PubMedCrossRefGoogle Scholar
  18. 18.
    Jakubíková, J., Sedlák, J., Mithen, R., et al. (2005). Role of PI3 K/Akt and MEK/ERK signaling pathways in sulforaphane- and erucin-induced phase II enzymes and MRP2 transcription, G2/M arrest and cell death in Caco-2 cells. Biochemical Pharmacology, 69(11), 1543–1552.PubMedCrossRefGoogle Scholar
  19. 19.
    Shan, Y., Wu, K., Wang, W., et al. (2009). Sulforaphane down-regulates COX-2 expression by activating p38 and inhibiting NF-kappaB-DNA-binding activity in human bladder T24 cells. International Journal of Oncology, 34(4), 1129–1134.PubMedGoogle Scholar
  20. 20.
    Choi, S., Lew, K. L., Xiao, H., et al. (2007). d,l-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Carcinogenesis, 28(1), 151–162.PubMedCrossRefGoogle Scholar
  21. 21.
    Mao, L., Wang, H. D., Wang, X. L., et al. (2010). Sulforaphane attenuates matrix metalloproteinase-9 expression following spinal cord injury in mice. Annals of Clinical and Laboratory Science, 40(4), 354–360.PubMedGoogle Scholar
  22. 22.
    Zhu, M., Zhang, Y., Cooper, S., et al. (2004). Phase II enzyme inducer, sulforaphane, inhibits UVB-induced AP-1 activation in human keratinocytes by a novel mechanism. Molecular Carcinogenesis, 41(3), 179–186.PubMedCrossRefGoogle Scholar
  23. 23.
    Huang, T. Y., Tsai, T. H., Hsu, C. W., et al. (2010). Curcuminoids suppress the growth and induce apoptosis through caspase-3-dependent pathways in glioblastoma multiforme (GBM) 8401 cells. Journal of Agriculture and Food Chemistry, 58(19), 10639–10645.CrossRefGoogle Scholar
  24. 24.
    Moquin, D. L., & Chan, F. K. (2010). The molecular regulation of programmed necrotic cell injury. Trends in Biochemical Sciences, 35(8), 434–441.PubMedCrossRefGoogle Scholar
  25. 25.
    Shih, Y. W., Wu, P. F., Lee, Y. C., et al. (2009). Myricetin suppresses invasion and migration of human lung adenocarcinoma A549 cells: Possible mediation by blocking the ERK signaling pathway. Journal of Agriculture and Food Chemistry, 57(9), 3490–3499.CrossRefGoogle Scholar
  26. 26.
    Karsy, M., Albert, L., Tobias, M. E., et al. (2010). All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner. Anticancer Research, 30(12), 4915–4920.PubMedGoogle Scholar
  27. 27.
    Chang, H. F., Huang, W. T., Chen, H. J., et al. (2010). Apoptotic effects of γ-mangostin from the fruit hull of Garcinia mangostana on human malignant glioma cells. Molecules, 15(12), 8953–8966.PubMedCrossRefGoogle Scholar
  28. 28.
    Juan, H. F., Chen, J. H., Hsu, W. T., et al. (2004). Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human. Proteomics, 4(9), 2766–2775.PubMedCrossRefGoogle Scholar
  29. 29.
    Lim, S. K., Llaguno, S. R., McKay, R. M., et al. (2011). Glioblastoma multiforme: A perspective on recent findings in human cancer and mouse models. BMB Reports, 44(3), 158–164.PubMedCrossRefGoogle Scholar
  30. 30.
    Khor, T. O., Keum, Y. S., Lin, W., et al. (2006). Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice. Cancer Research, 66(2), 613–621.PubMedCrossRefGoogle Scholar
  31. 31.
    Park, C., Moon, D. O., Choi, I. W., et al. (2007). Curcumin induces apoptosis and inhibits prostaglandin E2 production in synovial fibroblasts of patients with rheumatoid arthritis. International Journal of Molecular Medicine, 20(3), 365–372.PubMedGoogle Scholar
  32. 32.
    Abdi, A., Sadraie, H., Dargahi, L., Khalaj, L., et al. (2011). Apoptosis inhibition can be threatening in Aβ-induced neuroinflammation, through promoting cell proliferation. Neurochemical Research, 36(1), 39–48.PubMedCrossRefGoogle Scholar
  33. 33.
    Zhao, Y., Sui, X., & Ren, H. (2010). From procaspase-8 to caspase-8: Revisiting structural functions of caspase-8. Journal of Cellular Physiology, 225(2), 316–320.PubMedCrossRefGoogle Scholar
  34. 34.
    Kuttan, G., Kumar, K. B., Guruvayoorappan, C., et al. (2007). Antitumor, anti-invasion, and antimetastatic effects of curcumin. Advances in Experimental Medicine and Biology, 595, 173–184.PubMedCrossRefGoogle Scholar
  35. 35.
    Kunnumakkara, A. B., Guha, S., Krishnan, S., et al. (2007). Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Research, 67(8), 3853–3861.PubMedCrossRefGoogle Scholar
  36. 36.
    Yoon, H., & Liu, R. H. (2007). Effect of selected phytochemicals and apple extracts on NF-kappaB activation in human breast cancer MCF-7 cells. Journal of Agriculture and Food Chemistry, 55(8), 3167–3173.CrossRefGoogle Scholar
  37. 37.
    Brunelli, D., Tavecchio, M., Falcioni, C., et al. (2010). The isothiocyanate produced from glucomoringin inhibits NF-κB and reduces myeloma growth in nude mice in vivo. Biochemical Pharmacology, 79(8), 1141–1148.PubMedCrossRefGoogle Scholar
  38. 38.
    Fimognari, C., & Hrelia, P. (2007). Sulforaphane as a promising molecule for fighting cancer. Mutation Research, 635(2–3), 90–104.PubMedGoogle Scholar
  39. 39.
    Roy, S. K., Srivastava, R. K., & Shankar, S. (2010). Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer. Journal of Molecular Biology, 5, 10.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of NeurosurgeryTainan Sin-Lau HospitalTainanTaiwan
  2. 2.Graduate Institute of Medical Science, College of Health SciencesChang Jung Christian UniversityTainanTaiwan
  3. 3.Innovative Research Center of Medicine, College of Health SciencesChang Jung Christian UniversityTainanTaiwan

Personalised recommendations